JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
JPMorgan BetaBuilders US Equity ETF
BBUS
$9.28B
| $1.82M | ﹤0.01% |
31,427
| – | – |
|
3302
Protagonist Therapeutics
PTGX
$9.8B
| $1.82M | ﹤0.01% |
258,467
-23,692
| -8% | -$235K |
|
3303
Akebia Therapeutics
AKBA
$241M
| $1.81M | ﹤0.01% |
287,090
-20,300
| -7% | -$96.5K |
|
3304
Sierra Bancorp
BSRR
$532M
| $1.8M | ﹤0.01% |
61,944
+6,102
| +11% | +$168K |
|
3305
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.5B
| $1.8M | ﹤0.01% |
42,944
+9,285
| +28% | +$372K |
|
3306
iShares US Energy ETF
IYE
$1.8B
| $1.79M | ﹤0.01% |
55,750
-80,962
| -59% | -$2.56M |
|
3307
International Seaways
INSW
$4.71B
| $1.79M | ﹤0.01% |
60,081
+576
| +1% | +$15K |
|
3308
PUT
DuPont de Nemours
DD
$19.5B
| $1.79M | ﹤0.01% |
22,162
| – | – |
|
3309
Otter Tail
OTTR
$3.9B
| $1.78M | ﹤0.01% |
34,722
+13,404
| +63% | +$696K |
|
3310
Interface
TILE
$2.24B
| $1.77M | ﹤0.01% |
106,960
-199,056
| -65% | -$3.2M |
|
|
SMC
3311
Summit Midstream
SMC
$480M
| $1.77M | ﹤0.01% |
35,759
+6,972
| +24% | +$418K |
|
|
BKCC
3312
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.77M | ﹤0.01% |
356,672
+76,819
| +27% | +$377K |
|
3313
Allegiant Air
ALGT
$2.36B
| $1.77M | ﹤0.01% |
10,153
-12,954
| -56% | -$2.14M |
|
|
MRLN
3314
DELISTED
Marlin Business Services Corp
MRLN
| $1.76M | ﹤0.01% |
80,306
-2,942
| -4% | -$66.8K |
|
3315
Renasant Corp
RNST
$4B
| $1.76M | ﹤0.01% |
49,694
+28,387
| +133% | +$1M |
|
3316
Ironwood Pharmaceuticals
IRWD
$674M
| $1.76M | ﹤0.01% |
132,045
-41,529
| -24% | -$458K |
|
|
FFG
3317
DELISTED
FBL Financial Group
FFG
| $1.76M | ﹤0.01% |
29,800
+9,302
| +45% | +$535K |
|
3318
Shore Bancshares
SHBI
$799M
| $1.75M | ﹤0.01% |
101,027
+12,426
| +14% | +$203K |
|
3319
CALL
Norwegian Cruise Line
NCLH
$8.98B
| $1.75M | ﹤0.01% |
30,000
| – | – |
|
3320
PUT
Under Armour
UAA
$2.3B
| $1.75M | ﹤0.01% |
81,000
+76,500
| +1,700% | +$1.49M |
|
3321
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.75B
| $1.75M | ﹤0.01% |
31,474
+914
| +3% | +$49.2K |
|
3322
Altisource Portfolio Solutions
ASPS
$65.6M
| $1.74M | ﹤0.01% |
11,278
+11,042
| +4,679% | +$1.69M |
|
|
CTRA
3323
CALL
DELISTED
Coterra Energy
CTRA
| $1.74M | ﹤0.01% |
100,000
| – | – |
|
|
CTRA
3324
PUT
DELISTED
Coterra Energy
CTRA
| $1.74M | ﹤0.01% |
100,000
| – | – |
|
3325
WisdomTree US SmallCap Dividend Fund
DES
$2.23B
| $1.74M | ﹤0.01% |
60,676
+5,389
| +10% | +$150K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.